Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v2-FR | Version v1-EN | |
|---|---|---|
| Language | French | English |
| Date Updated | 2017-08-24 | 2017-08-24 |
| Drug Identification Number | 00742619 | 00742619 |
| Brand name | AMINOSYN II 10% | AMINOSYN II 10% |
| Common or Proper name | Aminosyn II | Aminosyn II |
| Company Name | ICU MEDICAL CANADA INC | ICU MEDICAL CANADA INC |
| Ingredients | HISTIDINE TRYPTOPHAN L-LYSINE L-ALANINE METHIONINE GLYCINE L-PROLINE L-ARGININE L-VALINE L-THREONINE L-ISOLEUCINE SERINE N-ACETYL-L-TYROSINE GLUTAMIC ACID L-ASPARTIC ACID L-PHENYLALANINE L-LEUCINE | HISTIDINE TRYPTOPHAN L-LYSINE L-ALANINE METHIONINE GLYCINE L-PROLINE L-ARGININE L-VALINE L-THREONINE L-ISOLEUCINE SERINE N-ACETYL-L-TYROSINE GLUTAMIC ACID L-ASPARTIC ACID L-PHENYLALANINE L-LEUCINE |
| Strength(s) | 300MG 200MG 1.05G 993MG 172MG 500MG 722MG 1.018G 500MG 400MG 1G 660MG 530MG 270MG 738MG 700MG 298MG 1G | 300MG 200MG 1.05G 993MG 172MG 500MG 722MG 1.018G 500MG 400MG 1G 660MG 530MG 270MG 738MG 700MG 298MG 1G |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | INTRAVENOUS | INTRAVENOUS |
| Packaging size | 1000ML & 2000ML | 1000ML & 2000ML |
| ATC code | B05BA | B05BA |
| ATC description | I.V. SOLUTIONS | I.V. SOLUTIONS |
| Reason for discontinuation | Business reasons | Business reasons |
| Anticipated discontinuation date | 2017-05-01 | 2017-05-01 |
| Actual discontinuation date | 2017-05-01 | 2017-05-01 |
| Remaining supply date | 2017-08-01 | 2017-08-01 |
| Discontinuation status | Discontinued | Discontinued |
| Discontinuation decision reversal | no | no |
| Tier 3 Status | No | No |
| Information on remaining supply | ||
| Company comments | ||
| Health Canada comments |